Vishal Navani
Calgary, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Consensus recommendations on surveillance and survivorship for patients with unresectable/stage IV non-small cell lung cancer after completing Immunotherapy: a Delphi study by Canadian experts.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 07, 2026
Corrigendum to "A non-randomized phase 2 trial of pembrolizumab in untreated patients with carcinoma of unknown primary site" [Eur J Cancer (2026) 239 116709].
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 17, 2026
Prophylactic Cranial Irradiation and Survival in Limited-Stage SCLC: A Multicenter Real-World Analysis From the Canadian SCLC Database (CASCADE).
Journal: JTO clinical and research reports
Published: March 11, 2026
Effectiveness and safety of immunotherapy in advanced NSCLC with pericardial effusions: a global retrospective multicenter study.
Journal: The oncologist
Published: February 16, 2026
Corrigendum to "Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)" [Lung Cancer 210 (2025) 108840].
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 17, 2025
A non-randomized phase 2 trial of pembrolizumab in untreated patients with carcinoma of unknown primary site.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 11, 2025
Factors Associated With Long-Term Survivors With Epidermal Growth Factor Receptor Positive Non-Small Cell Lung Cancer Treated With First or Second-Generation Tyrosine Kinase Inhibitors: A Canadian Multi-Center Cohort.
Journal: Asia-Pacific journal of clinical oncology
Published: August 21, 2025
Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 17, 2025
Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study.
Journal: Journal for immunotherapy of cancer
Published: January 03, 2025
Immunotherapy for Early-Stage Non-Small Cell Lung Cancer: A Practical Guide of Current Controversies.
Journal: Clinical lung cancer
Published: October 02, 2024
Real-world survival outcomes, treatment patterns, and impact of PD-L1 expression among patients with unresectable, stage III NSCLC treated with CRT → durvalumab in Canada: The RELEVANCE study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 24, 2024
Last Updated: 09/26/2026